First human test: new Injection's safety checked in healthy adults
NCT ID NCT06935266
Summary
This early-stage study aimed to check how safe and well-tolerated a new injection called TAK-881 is in healthy people. The trial involved 64 healthy adults who received the injection under their skin to see if they could complete the dose without significant side effects. Researchers monitored participants for about 19 weeks to gather initial safety data on this new formulation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Celerion
Tempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.